Under-treatment of elderly patients with ovarian cancer: a population based study
Open Access
- 26 November 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-10
Abstract
Ovarian cancer is the fourth most common cancer among women in France, and mainly affects the elderly. The primary objective of this study was to compare treatment of ovarian cancer according to age. All patients with invasive cancer (n = 1151) diagnosed between 1997 and 2011 in the Herault Department of southern France were included. Demographic data (age, area of residence), cancer characteristics (stage, histology, grade) and treatment modality (type, period and location of treatment) were analysed. Univariate and multivariate logistic regression was used to compare treatment by age. Ovarian cancer was less treated in elderly compared to younger patients, regardless of the type of treatment. This difference was more pronounced for chemotherapy, and was maximal for surgery followed by chemotherapy (odds ratio (OR) for surgery for patients aged >70 vs those aged 70 vs 70 vs <70 = 0.14 [0.08–0.28]). This effect of age was independent of other variables, including stage and grade. The probability of receiving standard treatment, in accordance with recommendations, was reduced by 50 % in elderly patients compared to their younger counterparts. Overall and net survival of elderly patients with standard treatment was similar to those of younger patients treated outside standard treatment. Elderly women with ovarian cancer were therapeutically disadvantaged compared to younger women. Further studies including co morbidities are necessary to refine these results and to improve therapeutic management of elderly patients with ovarian cancer.Keywords
This publication has 26 references indexed in Scilit:
- Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patientsGynecologic Oncology, 2012
- Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methodsInternational Journal of Cancer, 2012
- Estimating net survival: the importance of allowing for informative censoringStatistics in Medicine, 2012
- On Estimation in Relative SurvivalBiometrics, 2011
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experienceCancer, 2010
- Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2008
- Ovarian cancer in younger vs older women: a population-based analysisBritish Journal of Cancer, 2006
- The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based studyGynecologic Oncology, 2005
- Poorer survival of elderly patients with ovarian cancer: a population-based studySurgical Oncology, 2004
- Patterns of Chemotherapy Use for Women With Ovarian Cancer: A Population-Based StudyJournal of Clinical Oncology, 2003